Experience

SiteOne Therapeutics to Be Acquired by Eli Lilly for up to $1 Billion

May 28, 2025

Cooley advised SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other neuronal hyperexcitability disorders, on its acquisition by Eli Lilly.

Read more

Related contacts

Laura Berezin
Partner, Seattle
Sara Semnani
Partner, Santa Monica
Rowook Park
Partner, San Diego
Charity Williams
Partner, San Diego
Rena Kaminsky
Special Counsel, Palo Alto
Todd Gluth
Partner, San Diego
Lila Hope
Partner, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto
Tucker Cochenour
Associate, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
David Fletcher
Partner, Washington, DC
Jamie Leigh
Partner, San Francisco
Carly Mitchell
Partner, Washington, DC
Jeremy Morrison
Partner, Washington, DC
Gerard O'Shea
Partner, New York
Marty Schenker
Senior Counsel , San Francisco
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Selin Akkan
Associate, Palo Alto
Mari Dugas
Associate, Washington, DC
Virat Gupta
Associate, Washington, DC
Eileen Leman
Associate, Los Angeles
Joseph Perry
Associate, Reston
Hannah Rausch
Associate, New York
Melody Van Horn
Senior Paralegal, Palo Alto

Related Practices & Industries

Admissions and credentials

New York

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.